In Vitro Activity of Rezafungin Against Planktonic and Biofilm Forms of <i>Candida albicans</i> and <i>Nakaseomyces glabratus</i> Clinical Isolates from Vascular Infections in Poland: A Pilot Study.

Pharmaceutics · 2026 · PMC12943897 · PMID 41754955

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A test probability of p < 0.05 was considered significant, and a test probability of p < 0.01 was considered highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

In Vitro Activity of Rezafungin Against Planktonic and Biofilm Forms of &lt;i&gt;Candida albicans&lt;/i&gt; and &lt;i&gt;Nakaseomyces glabratus&lt;/i&gt; Clinical Isolates from Vascular Infections in Poland: A Pilot Study.

The sentences

In Vitro Activity of Rezafungin Against Planktonic and Biofilm Forms of <i>Candida albicans</i> and <i>Nakaseomyces glabratus</i> Clinical Isolates from Vascular Infections in Poland: A Pilot Study.